US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Cleveland BioLabs

3.17

0.0000

Volume:- -

Turnover:- -

Market Cap:107.66M

PE:-4.27

High:3.17

Open:3.17

Low:3.17

Close:3.17

52wk High:10.97

52wk Low:1.62

Shares:33.96M

Float Shares:33.63M

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.7424

EPS(LYR):-0.5610

ROE:-31.86%

ROA:-20.33%

PB:-23.01

PE(LYR):-5.65

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Cleveland BioLabs

Exchange:

NASDAQ

Establishment Date:

- -

Employees:

- -

Office Location:

- -

Website:

http://www.cytocom.com

Zip Code:

- -

Phone:

- -

Fax:

- -

Introduction:

Cytocom, Inc., a clinical-stage biopharmaceutical company, develops novel small molecule immunotherapies targeting cancer, autoimmune, inflammatory, and infectious diseases. Its platform, Advanced Immunomodulating Multi-receptor System (AIMS), offers noroxymorphone analogs multi-receptor modulating therapies and proenkephalin analogs multi-receptor modulating therapies. The company also has various clinical-stage development programs, including CYTO-200 for Crohn's disease, fibromyalgia, multiple sclerosis, and covid-19; CYTO-400 for hepatocellular and pancreatic cancer; and CYTO-600 for acute radiation syndrome, advanced solid tumors, and vaccine adjuvant. Cytocom, Inc. has a collaboration agreement with the La Jolla Institute for Immunology for research and development of new immune-modulating agents targeting toll-like receptors for the treatment of cancer, infectious, autoimmune, and chronic inflammatory diseases. The company is based in Fort Collins, Colorado.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Trading app for stocks, options & ETFs","description":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","keywords":"tiger brokers,tiger brokers au,tiger brokers australia,tiger trade,tiger trading,australia stock platform,US option,US stocks,stocks and options,australian trading platform,online broker australia,stock trading apps,mobile trading app,desktop trading,chess sponsored brokers,share trading platform","social":{"ogDescription":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CBLI/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"CBLI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CBLI\",,,,,undefined,":{"symbol":"CBLI","market":"US","secType":"STK","nameCN":"Cleveland BioLabs","latestPrice":3.17,"timestamp":1630440000000,"preClose":3.17,"halted":8,"volume":0,"delay":0,"changeRate":0,"floatShares":33633122,"shares":33961397,"eps":-0.742434,"marketStatus":"Market Closed","change":0,"latestTime":"08-31 16:00:00 EDT","open":3.17,"high":3.17,"low":3.17,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.742434,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1771837200000},"marketStatusCode":7,"symbolChange":{"newSymbol":"STAB","executeDate":"2021-09-01"},"adr":0,"adrRate":0,"listingDate":1153454400000,"exchange":"NASDAQ","adjPreClose":3.17,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CBLI\",,,,,undefined,":{"symbol":"CBLI","floatShares":33633122,"roa":"-20.33%","roe":"-31.86%","lyrEps":-0.560974,"shares":33961397,"dividePrice":0,"high":3.17,"amplitude":0,"preClose":3.17,"low":3.17,"week52Low":1.62,"pbRate":"-23.01","week52High":10.9718,"institutionHeld":0.0254,"latestPrice":3.17,"eps":-0.742434,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.742434,"open":3.17},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CBLI\",params:#limit:5,,,undefined,":[{"market":"US","date":"2021-09-01","symbol":"CBLI","oldSymbol":"CBLI","defaultRemindTime":1630503000000,"newSymbol":"STAB","exchange":"NASDAQ","type":"symbolChange","dateTimestamp":1630468800000},{"market":"US","date":"2021-08-16","symbol":"CBLI","fiscalQuarterEnding":"2021/06","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1629086400000,"reportTimeType":"pre","actualEps":-0.04},{"market":"US","date":"2020-12-31","symbol":"CBLI","fiscalQuarterEnding":"2020/09","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1609390800000,"reportTimeType":"","actualEps":-0.04},{"market":"US","date":"2020-05-15","symbol":"CBLI","fiscalQuarterEnding":"2020/03","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1589515200000,"reportTimeType":"pre","actualEps":-0.05},{"market":"US","date":"2019-11-14","symbol":"CBLI","fiscalQuarterEnding":"2019/09","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1573707600000,"reportTimeType":"","actualEps":-0.04}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CBLI\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CBLI\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CBLI\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CBLI","date":"2021-08-31","current":-4.26974,"percent":0.458738,"low":-52.824616,"twenty":-15.425424,"median":-5.157155,"eighty":-1.832923,"high":388.25966,"avg":7.416056,"sd":74.849212,"marketCap":116147977},"quantilePoints":[{"date":"2021-02-26","current":-34.182433,"twenty":-14.579856,"median":-4.372016,"eighty":-1.723269,"marketCap":82415692},{"date":"2021-03-05","current":-37.562413,"twenty":-14.763911,"median":-4.439384,"eighty":-1.74703,"marketCap":90565005},{"date":"2021-03-12","current":-37.817505,"twenty":-14.848611,"median":-4.522428,"eighty":-1.767755,"marketCap":91180047},{"date":"2021-03-19","current":-41.261258,"twenty":-14.928277,"median":-4.624064,"eighty":-1.779947,"marketCap":99483121},{"date":"2021-03-26","current":-35.859444,"twenty":-15.017016,"median":-4.68111,"eighty":-1.792138,"marketCap":86007334},{"date":"2021-04-01","current":-33.860086,"twenty":-15.143646,"median":-4.746392,"eighty":-1.792616,"marketCap":81211961},{"date":"2021-04-09","current":-38.181278,"twenty":-15.381162,"median":-4.830199,"eighty":-1.802371,"marketCap":91576154},{"date":"2021-04-16","current":-38.568251,"twenty":-15.610372,"median":-4.906041,"eighty":-1.816521,"marketCap":92504291},{"date":"2021-04-23","current":-31.538252,"twenty":-15.813114,"median":-5.034944,"eighty":-1.818787,"marketCap":75643141},{"date":"2021-04-30","current":-35.472471,"twenty":-15.974877,"median":-5.085748,"eighty":-1.828161,"marketCap":85079197},{"date":"2021-05-07","current":-34.053572,"twenty":-16.016893,"median":-5.163362,"eighty":-1.828712,"marketCap":81676029},{"date":"2021-05-14","current":-29.151922,"twenty":-16.212362,"median":-5.249933,"eighty":-1.839826,"marketCap":69919631},{"date":"2021-05-21","current":-33.730929,"twenty":-16.212362,"median":-5.249933,"eighty":-1.839826,"marketCap":79200998},{"date":"2021-05-28","current":-34.060333,"twenty":-16.212362,"median":-5.249933,"eighty":-1.839826,"marketCap":79974445},{"date":"2021-06-04","current":-34.982663,"twenty":-16.212362,"median":-5.249933,"eighty":-1.839826,"marketCap":82140097},{"date":"2021-06-11","current":-36.102635,"twenty":-16.212362,"median":-5.249933,"eighty":-1.839826,"marketCap":84769818},{"date":"2021-06-18","current":-31.95215,"twenty":-16.212362,"median":-5.249933,"eighty":-1.839826,"marketCap":75024383},{"date":"2021-06-25","current":-33.533287,"twenty":-16.180697,"median":-5.247502,"eighty":-1.839467,"marketCap":78736930},{"date":"2021-07-02","current":-37.156727,"twenty":-16.180697,"median":-5.247502,"eighty":-1.839467,"marketCap":87244849},{"date":"2021-07-09","current":-31.886269,"twenty":-16.180697,"median":-5.247502,"eighty":-1.839467,"marketCap":74869693},{"date":"2021-07-16","current":-27.274619,"twenty":-16.149032,"median":-5.234514,"eighty":-1.839108,"marketCap":64041432},{"date":"2021-07-23","current":-31.293343,"twenty":-16.149032,"median":-5.234514,"eighty":-1.839108,"marketCap":73477488},{"date":"2021-07-28","current":-32.87448,"twenty":-16.149032,"median":-5.234514,"eighty":-1.839108,"marketCap":77190035},{"date":"2021-08-13","current":-6.637051,"twenty":-15.848059,"median":-5.169569,"eighty":-1.83539,"marketCap":111053768},{"date":"2021-08-20","current":-6.292005,"twenty":-15.731226,"median":-5.169569,"eighty":-1.83539,"marketCap":105280330},{"date":"2021-08-27","current":-7.063283,"twenty":-15.550463,"median":-5.157155,"eighty":-1.832923,"marketCap":118185661},{"date":"2021-08-31","current":-6.941503,"twenty":-15.425424,"median":-5.157155,"eighty":-1.832923,"marketCap":116147977}],"updateTime":1771715786984},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.cytocom.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.0113},{"period":"1month","weight":0.0059},{"period":"3month","weight":0.0461},{"period":"6month","weight":0.0684},{"period":"1year","weight":0.1295},{"period":"ytd","weight":0.011}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Cytocom, Inc., a clinical-stage biopharmaceutical company, develops novel small molecule immunotherapies targeting cancer, autoimmune, inflammatory, and infectious diseases. Its platform, Advanced Immunomodulating Multi-receptor System (AIMS), offers noroxymorphone analogs multi-receptor modulating therapies and proenkephalin analogs multi-receptor modulating therapies. The company also has various clinical-stage development programs, including CYTO-200 for Crohn's disease, fibromyalgia, multiple sclerosis, and covid-19; CYTO-400 for hepatocellular and pancreatic cancer; and CYTO-600 for acute radiation syndrome, advanced solid tumors, and vaccine adjuvant. Cytocom, Inc. has a collaboration agreement with the La Jolla Institute for Immunology for research and development of new immune-modulating agents targeting toll-like receptors for the treatment of cancer, infectious, autoimmune, and chronic inflammatory diseases. The company is based in Fort Collins, Colorado.","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.440046},{"month":2,"riseRate":0.466667,"avgChangeRate":0.034696},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.038641},{"month":4,"riseRate":0.533333,"avgChangeRate":0.08618},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.042743},{"month":6,"riseRate":0.6,"avgChangeRate":0.046106},{"month":7,"riseRate":0.357143,"avgChangeRate":-0.046329},{"month":8,"riseRate":0.4375,"avgChangeRate":-0.064742},{"month":9,"riseRate":0.666667,"avgChangeRate":0.060809},{"month":10,"riseRate":0.4,"avgChangeRate":-0.032767},{"month":11,"riseRate":0.4,"avgChangeRate":-0.040879},{"month":12,"riseRate":0.266667,"avgChangeRate":-0.050803}],"exchange":"NASDAQ","name":"Cleveland BioLabs","nameEN":"Cleveland BioLabs"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"CBLI\",market:\"US\",,,undefined,":null}}